Berkshire Bank Has $201,000 Holdings in Sanofi (NASDAQ:SNY)

Berkshire Bank decreased its holdings in shares of Sanofi (NASDAQ:SNY) by 5.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,177 shares of the company’s stock after selling 258 shares during the quarter. Berkshire Bank’s holdings in Sanofi were worth $201,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in SNY. Stablepoint Partners LLC raised its stake in Sanofi by 0.8% during the 3rd quarter. Stablepoint Partners LLC now owns 23,893 shares of the company’s stock worth $1,377,000 after buying an additional 189 shares during the period. PDS Planning Inc lifted its stake in Sanofi by 3.1% during the 3rd quarter. PDS Planning Inc now owns 6,643 shares of the company’s stock valued at $383,000 after acquiring an additional 200 shares in the last quarter. Eagle Ridge Investment Management raised its holdings in shares of Sanofi by 3.8% in the third quarter. Eagle Ridge Investment Management now owns 5,571 shares of the company’s stock valued at $321,000 after purchasing an additional 203 shares during the last quarter. Financial Advocates Investment Management increased its stake in Sanofi by 3.4% in the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock valued at $365,000 after buying an additional 206 shares during the last quarter. Finally, Angeles Investment Advisors LLC lifted its holdings in Sanofi by 1.9% during the third quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock worth $653,000 after acquiring an additional 210 shares during the period. Institutional investors own 14.04% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Stock Performance

Shares of SNY stock opened at $53.34 on Tuesday. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97. The firm’s 50 day moving average is $48.80 and its 200 day moving average is $52.21. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $135.37 billion, a P/E ratio of 27.21, a PEG ratio of 1.19 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. The business had revenue of $13.44 billion for the quarter, compared to analysts’ expectations of $16.59 billion. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.55 EPS. On average, sell-side analysts anticipate that Sanofi will post 3.82 earnings per share for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.